healthcare

Image for Fresenius Medical Care's meek 2026 guidance sends shares fallingFinance

Fresenius Medical Care's Meek 2026 Guidance Sends Shares Falling

Image for Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugsFinance

Analysis-Novo's Stumbles Burnish Lilly's Widening Lead in Weight-Loss Drugs

Image for Italian region resists US pressure to curb use of Cuban doctorsFinance

Italian Region Resists US Pressure to Curb Use of Cuban Doctors

Image for Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of deathFinance

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk of Death

Image for Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say

Instant View: Novo's CagriSema Setback May Shift Investor Focus to M&A Strategy, Analysts Say

Date: February 23, 2026

Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than Eli Lilly's Zepbound in a head-to-head trial, a fresh blow to the Danish drugmaker's efforts to...

Image for Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out

Novo Nordisk's $475-billion Rise and Fall as Wegovy-Era Gains Wiped Out

Date: February 23, 2026

Feb 23 (Reuters) - Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wegovy's launch had brought, after the drugmaker said its next-generation obesity drug CagriSema...

Image for Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly

Novo Nordisk's CagriSema Trial Deals Blow in Obesity Drug Battle With Eli Lilly

Date: February 23, 2026

COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema did not meet the primary endpoint in a trial designed to show it was non-inferior to competitor Eli...

Image for India's LTIMindtree wins $100 million deal with European medtech firm

India's LTIMindtree Wins $100 Million Deal With European Medtech Firm

Date: February 23, 2026

Feb 23 (Reuters) - Indian IT services company LTIMindtree on Monday said it has won a $100 million deal with a medical technology company in Europe. (Reporting by Nishit Navin; Editing by Mrigank...

Image for Sonova expects FY revenue at lower end of target range, CEO says in interview

Sonova Expects Fy Revenue at Lower End of Target Range, CEO Says in Interview

Date: February 20, 2026

Feb 20 (Reuters) - Sonova's full year revenue will come at the lower end of its 2025/2026 forecast range for growth of 5% to 9%, hearing-aid maker CEO Eric Bernard said in an interview published on...

Image for EU approves higher dose of Novo Nordisk's Wegovy

EU Approves Higher Dose of Novo Nordisk's Wegovy

Date: February 17, 2026

Feb 17 (Reuters) - The European Commission has approved a higher dose of Novo Nordisk's popular weight-loss drug Wegovy, the Danish drugmaker said on Tuesday. (Reporting by Mariam Sunny in Bengaluru;...